Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Events

26 Oct 2026 - 29 Oct 2026
16 Nov 2026 - 19 Nov 2026

Acetominophen Protects Against Heart Damage

By HospiMedica staff writers
Posted on 06 Aug 2002
The medicine in the pain reliever acetominophen (Tylenol) has been linked to improved heart muscle recovery after ischemic attacks. More...


Researchers at Rutgers, the State University of New Jersey (Brunswick, USA) have reported finding significant improvement in hearts treated with acetaminophen following periods of induced ischemia, compared to nontreated hearts. The rapid post-ischemia recovery of heart muscle was attributed to the antioxidant properties of acetaminophen.

"We now have results from several published studies that suggest acetaminophen exerts an antioxidant effect on heart muscle cells, blocking the damage caused by chemicals known as oxidants,” said Gary F. Merrill, a professor in the department of cell biology and neuroscience at Rutgers, who has been conducting research on the effects of acetaminophen on the heart for several years. Until further studies confirm the benefit, however, Prof. Merrill cautions that current acetaminophen users should not deviate from their recommended dosages.

Similar findings by Dr. Addison Taylor at Baylor College of Medicine (Houston, TX, USA) and Prof. Philip Greenspan of the University of Chicago College of Pharmacy (IL, USA) also indicate that acetaminophen may play a role in preventing some of the damaging effects of cardiovascular disease. In addition, separate investigations by Drs. Taylor and Greenspan show that acetaminophen may help protect against hardening of the arteries.



Related Links:
Rutgers

Gold Member
Blood Gas Analyzer
i-Check200
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Medical-Grade Display
HL2316SHTB
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Half-matched bone marrow transplant expands access to curative treatment for children and young adults with severe aplastic anemia. (Photo courtes of Margarita Dionysiou using Bio Render)

Half-Matched Family Donors Could Expand Transplant Access for Severe Aplastic Anemia

Severe aplastic anemia is a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells, leaving children and young adults vulnerable to anemia, infection, and bleeding.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.